We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
-1.53%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$23.8B
AUM Growth
-$2.11B
Cap. Flow
-$941M
Cap. Flow %
-3.95%
Top 10 Hldgs %
24.95%
Holding
1,082
New
165
Increased
347
Reduced
405
Closed
129

Sector Composition

Rank Sector Weight
1 Technology 30.74%
2 Financials 13.54%
3 Consumer Discretionary 13.12%
4 Industrials 11.88%
5 Healthcare 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXT icon
1051
Rackspace Technology
RXT
$1.02B
-680,435
Closed -$661K
RYAM icon
1052
Rayonier Advanced Materials
RYAM
$569M
-169,600
Closed -$999K
SCCO icon
1053
Southern Copper
SCCO
$143B
-213,228
Closed -$30M
SIG icon
1054
Signet Jewelers
SIG
$3.48B
-11,586
Closed -$960K
SKIL icon
1055
Skillsoft
SKIL
$55.8M
-80,123
Closed -$745K
SLAB icon
1056
Silicon Laboratories
SLAB
$7.15B
-119,420
Closed -$15.6M
SNV
1057
DELISTED
Synovus
SNV
-318,955
Closed -$16M
SRE icon
1058
Sempra
SRE
$61.1B
-4,696
Closed -$415K
STKL
1059
DELISTED
SunOpta
STKL
-48,245
Closed -$183K
STLD icon
1060
Steel Dynamics
STLD
$34.7B
-3,906
Closed -$662K
STOK icon
1061
Stoke Therapeutics
STOK
$1.85B
-12,878
Closed -$409K
SVV icon
1062
Savers
SVV
$1.39B
-37,162
Closed -$347K
TBI
1063
Trueblue
TBI
$232M
-75,956
Closed -$346K
TBPH icon
1064
Theravance Biopharma
TBPH
$874M
-30,444
Closed -$570K
TG icon
1065
Tredegar Corp
TG
$270M
-23,725
Closed -$170K
TNYA icon
1066
Tenaya Therapeutics
TNYA
$168M
-75,927
Closed -$54K
TPH
1067
DELISTED
Tri Pointe Homes
TPH
-866,162
Closed -$27.3M
TTEK icon
1068
Tetra Tech
TTEK
$7.93B
-24,613
Closed -$826K
TWST icon
1069
Twist Bioscience
TWST
$5.76B
-103,117
Closed -$3.27M
USB icon
1070
US Bancorp
USB
$98.7B
-6,446
Closed -$344K
AD
1071
Array Digital Infrastructure
AD
$2.95B
-23,898
Closed -$1.28M
VRTX icon
1072
Vertex Pharmaceuticals
VRTX
$120B
-17,416
Closed -$7.9M
WVE icon
1073
Wave Life Sciences
WVE
$1.11B
-338,546
Closed -$5.76M
XRX icon
1074
Xerox
XRX
$341M
-1,356,142
Closed -$3.21M
ZNTL icon
1075
Zentalis Pharmaceuticals
ZNTL
$317M
-124,525
Closed -$168K

Similar funds

Jacobs Levy Equity Management's Q1 2026 Portfolio in Review

As of Q1 2026, Jacobs Levy Equity Management held 1,082 positions worth $23.8B, down 8.1% from $25.9B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Jacobs Levy Equity Management withdrew a net $941M in Q1 2026, closing 129 positions and reducing 405 holdings. Its most notable exit was Illumina, an estimated $53.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Jacobs Levy Equity Management opened a new position in Texas Instruments worth $166M.

  • Jacobs Levy Equity Management's largest Q1 2026 buy was Texas Instruments: 857,024 shares worth $166M.
  • Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2026, an estimated $293M increase.
  • Jacobs Levy Equity Management's biggest Q1 2026 reduction was Lam Research, cutting an estimated $284M.
  • Jacobs Levy Equity Management fully exited Illumina in Q1 2026, selling an estimated $53.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 25% of its $23.8B portfolio in Q1 2026.
  • Jacobs Levy Equity Management opened 165 new positions and closed 129 in Q1 2026.
  • Jacobs Levy Equity Management's portfolio value fell 8.1% quarter-over-quarter to $23.8B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.